Nektar Therapeutics (NKTR)
82.00
-3.09
(-3.63%)
USD |
NASDAQ |
May 07, 12:59
Nektar Therapeutics SG&A Expense (TTM) : 68.67M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Boston Scientific Corp. | 7.072B |
| Eli Lilly & Co. | 11.56B |
| Soleno Therapeutics, Inc. | 132.13M |
| Aquestive Therapeutics, Inc. | 79.85M |
| Regeneron Pharmaceuticals, Inc. | 2.715B |